Cognition Therapeutics (CGTX) Q2 2024 Earnings

7MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.27
-0.18
-0.09
0

Details

Expected EPS
-0.246533
Actual EPS
-0.27
Surprise EPS
-0.02
Surprise Percent
+9.52%

Description

Cognition Therapeutics (CGTX) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts